Chemoprevention of Oral Premalignant Lesions
NCT00036283
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Precancerous Conditions
Interventions
DRUG:
Celecoxib
Sponsor
Pfizer